GARDNER JASON 4
4 · Magenta Therapeutics, Inc. · Filed Jan 3, 2020
Insider Transaction Report
Form 4
GARDNER JASON
DirectorSee Remarks
Transactions
- Sale
Common Stock
2020-01-02$15.10/sh−2,800$42,280→ 262,412 total
Holdings
- 292,990(indirect: By Trust)
Common Stock
- 359,092(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]This trade is pursuant to an active 10b5-1 plan.